MIRA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRA and other ETFs, options, and stocks.

About MIRA

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. 

CEO
Erez Aminov
CEOErez Aminov
Employees
5
Employees5
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2020
Founded2020
Employees
5
Employees5

MIRA Key Statistics

Market cap
34.93M
Market cap34.93M
Price-Earnings ratio
-3.29
Price-Earnings ratio-3.29
Dividend yield
Dividend yield
Average volume
6.06M
Average volume6.06M
High today
$1.72
High today$1.72
Low today
$1.43
Low today$1.43
Open price
$1.54
Open price$1.54
Volume
2.88M
Volume2.88M
52 Week high
$5.01
52 Week high$5.01
52 Week low
$0.616
52 Week low$0.616

People also own

Based on the portfolios of people who own MIRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.